United States Department of Agriculture NIFA Awards ImpeDx Grant

June, 2019

Impedx has been awarded a Phase-1 Small Business Innovation Research (SBIR) grant from the National Institute of Food and Agriculture, USDA to develop and evaluate use of our technology to identifying spoilage in biofuel feedstocks.  Specifically, applying our electronic detection system to yeast culture inoculums.  “This project demonstrates the breadth of application of our technology and skill sets - we are excited about the opportunity to work with NIFA USDA and look forward to successful execution of our proposed work plan” stated Roy Swiger, CEO. Click here for the NIFA USDA Homepage

 

ABOUT IMPEDX DIAGNOSTICS

Overland Park, KS – ImpeDx Diagnostics (a privately held company) is developing a multiplexed phenotypic diagnostic system to perform extremely rapid Antibiotic Susceptibility Testing (AST) on a variety of different patient sample types (swabs, blood, urine, sputum, etc.) that will allow clinicians to provide targeted, effective antibiotics to patients in hours, rather than days or weeks as with currently available products.   Our system compliments existing rapid pathogen identification systems already on the market and provides the full answer clinicians require in order to implement appropriate patient care, improving patient outcomes while substantially reducing healthcare costs and the fostering of antibiotic resistance.  For more information, visit www.impedx.com.

CONTACT:

ImpeDx Diagnostics

Dr Roy R Swiger, CEO

roy@impedx.com